196 related articles for article (PubMed ID: 36214649)
1. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer.
Zhu Q; Zhang C; Qu T; Lu X; He X; Li W; Yin D; Han L; Guo R; Zhang E
Cancer Res; 2022 Dec; 82(23):4340-4358. PubMed ID: 36214649
[TBL] [Abstract][Full Text] [Related]
2. MYC-Activated LncRNA
Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
[TBL] [Abstract][Full Text] [Related]
3. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma.
Ye Y; Gu B; Wang Y; Shen S; Huang W
J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161
[TBL] [Abstract][Full Text] [Related]
4. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
Liu H; Han L; Liu Z; Gao N
J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
Liu S; Li H; Zhu Y; Ma X; Shao Z; Yang Z; Cai C; Wu Z; Li M; Gong W; Wu X
Cancer Lett; 2022 Oct; 547():215862. PubMed ID: 35953000
[TBL] [Abstract][Full Text] [Related]
7. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
Lv D; Wang Y; Li S; Shao X; Jin Q
Mol Biotechnol; 2023 Jan; 65(1):72-83. PubMed ID: 35819746
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
Li F; Chen Q; Xue H; Zhang L; Wang K; Shen F
Cell Death Dis; 2020 Oct; 11(10):894. PubMed ID: 33093444
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
[TBL] [Abstract][Full Text] [Related]
15. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
17. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
19. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]